The WFH PACT Program was launched in 2021 and is active in twenty countries worldwide. Each country is responsible for developing a national access plan that includes personalized training, outreach, and advocacy components to increase support from national governments for bleeding disorders programs. Today, as we are at the midpoint of this five-year global initiative, we are happy to share that in two years, the Program has contributed to a notable increase in the level of care in the target countries.
The PACT Program helps us identify new patients in the country. After seeing the numbers of diagnosed PWBDs, our government expressed willingness to begin purchasing treatment products. We are now in the preliminary stages of discussion to pursue this endeavor with our government.
—Megan Buckie Adediran, Hemophilia Foundation of Nigeria, Nigeria
Some of the achievements covered in the report include the following:
To find out more about what the Program has done around the world—and to read some inspirational case studies—please view the report here.
To learn more about the WFH Path to Access to Care and Treatment (PACT) Program, please click here.
The PACT Program is supported by funding from Roche and Sanofi, our visionary partners; CSL Behring and Pfizer, our leadership partners; and Bayer, Biotest and Grifols, our collaborating partners.